George R. Thompson

20.1k total citations · 3 hit papers
296 papers, 9.9k citations indexed

About

George R. Thompson is a scholar working on Epidemiology, Infectious Diseases and Small Animals. According to data from OpenAlex, George R. Thompson has authored 296 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 189 papers in Epidemiology, 184 papers in Infectious Diseases and 25 papers in Small Animals. Recurrent topics in George R. Thompson's work include Antifungal resistance and susceptibility (171 papers), Fungal Infections and Studies (157 papers) and Nail Diseases and Treatments (52 papers). George R. Thompson is often cited by papers focused on Antifungal resistance and susceptibility (171 papers), Fungal Infections and Studies (157 papers) and Nail Diseases and Treatments (52 papers). George R. Thompson collaborates with scholars based in United States, Spain and Australia. George R. Thompson's co-authors include Thomas F. Patterson, Nathan P. Wiederhold, Jo‐Anne H. Young, Dimitrios P. Kontoyiannis, M. Hong Nguyen, Thomas J. Walsh, Raoul Herbrecht, David A. Stevens, Brahm H. Segal and John E. Bennett and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

George R. Thompson

277 papers receiving 9.5k citations

Hit Papers

3 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

2016 1.8k citations George R. Thompson, Thomas J. Walsh et al. Clinical Infectious Diseases profile →
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

2021 283 citations Martin Hoenigl, Oliver A. Cornely et al. profile →
Impact of climate change and natural disasters on fungal infections

2024 83 citations Oliver A. Cornely, George R. Thompson et al. The Lancet Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George R. Thompson United States	50	6.8k	6.2k	857	835	807	296	9.9k
Katrien Lagrou Belgium	50	7.0k 1.0×	6.0k 1.0×	718 0.8×	733 0.9×	840 1.0×	297	9.2k
Malcolm Richardson United Kingdom	55	7.5k 1.1×	6.1k 1.0×	1.4k 1.6×	974 1.2×	1.2k 1.5×	263	11.3k
John W. Baddley United States	52	5.7k 0.8×	5.8k 0.9×	529 0.6×	547 0.7×	487 0.6×	183	9.0k
Martin Hoenigl Austria	49	6.9k 1.0×	5.5k 0.9×	633 0.7×	698 0.8×	757 0.9×	294	8.5k
B. Dupont France	53	6.7k 1.0×	6.2k 1.0×	560 0.7×	1.1k 1.3×	460 0.6×	191	9.3k
Brahm H. Segal United States	55	6.7k 1.0×	5.9k 1.0×	1.9k 2.2×	1.0k 1.2×	1.4k 1.7×	162	12.7k
Andreas H. Groll Germany	59	9.6k 1.4×	8.3k 1.3×	761 0.9×	1.2k 1.5×	1.0k 1.3×	288	12.6k
Brunella Posteraro Italy	58	6.0k 0.9×	5.1k 0.8×	2.0k 2.3×	378 0.5×	534 0.7×	281	10.3k
E. Anaissie United States	52	5.2k 0.8×	4.5k 0.7×	1.3k 1.5×	738 0.9×	591 0.7×	137	9.0k
Emmanuel Roilides Greece	62	10.7k 1.6×	9.3k 1.5×	1.3k 1.5×	1.3k 1.6×	1.2k 1.4×	432	15.8k

Countries citing papers authored by George R. Thompson

Since Specialization

Citations

This map shows the geographic impact of George R. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George R. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George R. Thompson more than expected).

Fields of papers citing papers by George R. Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George R. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George R. Thompson. The network helps show where George R. Thompson may publish in the future.

Co-authorship network of co-authors of George R. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of George R. Thompson. A scholar is included among the top collaborators of George R. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George R. Thompson. George R. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, George R., Monica Donnelley, Jaime Figueroa, et al.. (2025). Liposomal amphotericin B and complement activation-related pseudoallergy (CARPA). Antimicrobial Agents and Chemotherapy. 69(3). e0169224–e0169224. 3 indexed citations

Sykes, Jane E., et al.. (2025). Use of Dog Serologic Data for Improved Understanding of Coccidioidomycosis: A One Health Approach. The Journal of Infectious Diseases. 231(5). e986–e995.

Donnelley, Monica, Sili Fan, Machelle Wilson, et al.. (2024). Utility of microbial cell free DNA next-generation sequencing for diagnosis and management of infectious diseases. Diagnostic Microbiology and Infectious Disease. 110(1). 116334–116334. 1 indexed citations

Barker, Bridget M., George R. Thompson, & Neil M. Ampel. (2024). Challenges to Implementing a Vaccine for Coccidioidomycosis. Open Forum Infectious Diseases. 11(6). ofae095–ofae095. 1 indexed citations

Maertens, Johan, Monica A. Slavin, Martin Hoenigl, et al.. (2024). Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate. Journal of Antimicrobial Chemotherapy. 79(8). 1786–1793. 2 indexed citations

Poplin, Victoria, Diego H. Cáceres, Patrícia Fernanda Herkert, et al.. (2024). Geographical distribution of the Cryptococcus gattii species complex: a systematic review. The Lancet Microbe. 5(12). 100921–100921. 5 indexed citations

Phillips, Matthew C., Regina C. LaRocque, & George R. Thompson. (2024). Infectious Diseases in a Changing Climate. JAMA. 331(15). 1318–1318. 22 indexed citations

Cornely, Oliver A., George R. Thompson, Àlex Soriano, et al.. (2024). P29 Treatment outcomes with rezafungin and caspofungin in people aged 65 years and above with candidaemia and/or invasive candidiasis: integrated analysis of pooled Phase 2 and Phase 3 data. JAC-Antimicrobial Resistance. 6(Supplement_1). 1 indexed citations

Nguyen, M. Hong, Luis Ostrosky‐Zeichner, Peter G. Pappas, et al.. (2023). Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry. Open Forum Infectious Diseases. 10(9). ofad424–ofad424. 15 indexed citations

10.

Desai, Angel N., et al.. (2023). Mpox Infection in Children—Infection Control Implications for Household Contacts. Open Forum Infectious Diseases. 10(2). ofad003–ofad003. 2 indexed citations

11.

Teixeira, Marcus de Melo, Jason Stajich, Jason W. Sahl, et al.. (2022). A chromosomal-level reference genome of the widely utilized Coccidioides posadasii laboratory strain “Silveira”. G3 Genes Genomes Genetics. 12(4). 12 indexed citations

12.

Messina, Julia A., Eileen K Maziarz, John N. Galgiani, et al.. (2021). A randomized, double-blind, placebo-controlled clinical trial of fluconazole as early empiric treatment of coccidioidomycosis pneumonia (Valley Fever) in adults presenting with community-acquired pneumonia in endemic areas (FLEET-Valley Fever). Contemporary Clinical Trials Communications. 24. 100851–100851. 6 indexed citations

13.

Donnelley, Monica, et al.. (2020). Aspiring Antifungals: Review of Current Antifungal Pipeline Developments. Journal of Fungi. 6(1). 28–28. 167 indexed citations

14.

Mead, Heather, Marcus de Melo Teixeira, Christopher S. Wendel, et al.. (2020). Differential Thermotolerance Adaptation between Species of Coccidioides. Journal of Fungi. 6(4). 366–366. 22 indexed citations

15.

Roe, Chandler C., Jolene R. Bowers, Hanna N. Oltean, et al.. (2018). Dating the Cryptococcus gattii Dispersal to the North American Pacific Northwest. mSphere. 3(1). 17 indexed citations

16.

Thompson, George R., Janis E. Blair, Michael Bolaris, et al.. (2017). Adjunctive Corticosteroid Therapy in the Treatment of Coccidioidal Meningitis. Clinical Infectious Diseases. 65(2). 338–341. 15 indexed citations

17.

Engelthaler, David M., Chandler C. Roe, Crystal M. Hepp, et al.. (2016). Local Population Structure and Patterns of Western Hemisphere Dispersal for Coccidioides spp., the Fungal Cause of Valley Fever. mBio. 7(2). e00550–16. 63 indexed citations

18.

Vu, Kiem, et al.. (2014). Invasion of the Central Nervous System by Cryptococcus neoformans Requires a Secreted Fungal Metalloprotease. mBio. 5(3). e01101–14. 116 indexed citations

19.

Thompson, George R., Derek J. Bays, Stuart H. Cohen, & Demosthenes Pappagianis. (2011). Fluoride Excess in Coccidioidomycosis Patients Receiving Long-Term Antifungal Therapy: an Assessment of Currently Available Triazoles. Antimicrobial Agents and Chemotherapy. 56(1). 563–564. 37 indexed citations

20.

Thompson, George R. & George Crawford. (2008). Pneumorachis caused by metastatic gas gangrene. Diagnostic Microbiology and Infectious Disease. 63(1). 108–110. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact